Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician and described the occurrence of intussusception in a 3.5-month-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline) for prophylaxis. On an unspecified date the subject received the 1st dose of ROTARIX (oral). Eight days after vaccination with the 1st dose of ROTARIX, the subject experienced intussusception. The physician considered the event was clinically significant (or requiring intervention). At the time of reporting the outcome of the event was unspecified. Follow up information received on 01 May 2008: the subject''s age is 3.5 months instead of years as initially reported. Further information has been requested (Targeted Follow-Up Questionnaire for intussusception), but it was impossible to obtain additional details from the reporter as she did not recall any more data of the event so as to complete the form; this case has been therefore considered closed.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166